Bond GlaxoSmithKline Capital PLC 0.534% ( US377373AL97 ) in USD
Issuer | GlaxoSmithKline Capital PLC |
Market price | 100 % ▲ |
Country | ![]() |
ISIN code |
![]() |
Interest rate | 0.534% per year ( payment 2 times a year) |
Maturity | 30/09/2023 - Bond has expired |
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
Minimal amount | 2 000 USD |
Total amount | 1 250 000 000 USD |
Cusip | 377373AL9 |
Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) |
Moody's rating | A2 ( Upper medium grade - Investment-grade ) |
Detailed description |
GlaxoSmithKline Capital PLC is a UK-based venture capital firm focused on life sciences investments, primarily supporting early-stage and growth-stage companies developing innovative therapies and technologies within GlaxoSmithKline's strategic areas of interest. The Bond issued by GlaxoSmithKline Capital PLC ( United Kingdom ) , in USD, with the ISIN code US377373AL97, pays a coupon of 0.534% per year. The coupons are paid 2 times per year and the Bond maturity is 30/09/2023 The Bond issued by GlaxoSmithKline Capital PLC ( United Kingdom ) , in USD, with the ISIN code US377373AL97, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by GlaxoSmithKline Capital PLC ( United Kingdom ) , in USD, with the ISIN code US377373AL97, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |